Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy
Aramchol Versus Placebo in the Treatment of HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy: A Randomized, Double-blinded, Allocation-concealed, Placebo-controlled Clinical Trial AramcholVersus Placebo in the Treatment of HIV-associated Nonalcoholic Fatty Liver Disease and Lipod ...